Novel nomogram to predict the overall survival of postoperative patients with gastric signet

BMC Gastroenterology

Research

Liru Wang¹  Enhong Shi¹  Chenyao Zhang¹  Xiaoxue Li¹  Ran Ding¹  Xuyao Wang²  Yan Zhang³  Donghui Liu⁴ 

[1] Department of Oncology, Heilongjiang Provincial Hospital, Harbin, China;Department of Pharmacy, Harbin Second Hospital, Harbin, China;School of Life Science and Technology, Harbin Institute of Technology, Harbin, China;School of Life Science and Technology, Harbin Institute of Technology, Harbin, China;Department of Oncology, Heilongjiang Provincial Hospital, Harbin, China;

关键词: Nomogram;    Signet ring cell carcinoma;    Risk factors;    Gastric cancer;    Prognosis;   

DOI  :  10.1186/s12876-023-02915-z

 received in 2023-05-16, accepted in 2023-08-05,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundThe TNM staging system cannot accurately predict the prognosis of postoperative gastric signet ring cell carcinoma (GSRC) given its unique biological behavior, epidemiological features, and various prognostic factors. Therefore, a reliable postoperative prognostic evaluation system for GSRC is required. This study aimed to establish a nomogram to predict the overall survival (OS) rate of postoperative patients with GSRC and validate it in the real world.MethodsClinical data of postoperative patients with GSRC from 2002 to 2014 were collected from the Surveillance, Epidemiology, and End Results database and randomly assigned to training and internal validation sets at a 7:3 ratio. The external validation set used data from 124 postoperative patients with GSRC who were admitted to the Affiliated Tumor Hospital of Harbin Medical University between 2002 and 2014. The independent risk factors affecting OS were screened using univariate and multivariate analyses to construct a nomogram. The performance of the model was evaluated using the C-index, receiver operating characteristic curve (ROC), calibration curve, decision analysis (DCA) curve, and adjuvant chemotherapy decision analysis.ResultsUnivariate/multivariate analysis indicated that age, stage, T, M, regional nodes optimized (RNE), and lymph node metastasis rate (LNMR) were independent risk factors affecting prognosis. The C-indices of the training, internal validation, and external validation sets are 0.741, 0.741, and 0.786, respectively. The ROC curves for the first, third, and fifth years in three sets had higher areas under the curves, (training set, 0.782, 0.864, 0.883; internal validation set, 0.781, 0.863, 0.877; external validation set, 0.819, 0.863, 0.835). The calibration curve showed high consistency between the nomogram-predicted 1-, 3-, and 5-year OS and the actual OS in the three queues. The DCA curve indicated that applying the nomogram enhanced the net clinical benefits. The nomogram effectively distinguished patients in each subgroup into high- and low-risk groups. Adjuvant chemotherapy can significantly improve OS in high-risk group (P = 0.034), while the presence or absence of adjuvant chemotherapy in low-risk group has no significant impact on OS (P = 0.192).ConclusionsThe nomogram can effectively predict the OS of patients with GSRC and may help doctors make personalized prognostic judgments and clinical treatment decisions.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

13690_2023_1154_Article_IEq17.gif

42004_2023_982_Article_IEq18.gif

13068_2023_2361_Article_IEq16.gif

Fig. 1

Fig. 3

42490_2023_74_Article_IEq59.gif

13690_2023_1172_Article_IEq6.gif

Fig. 1